Track the 일동제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 일동제약 has logged 1 insider filings. Market capitalisation: €432.9bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 조노제. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Il Dong Pharmaceutical 是一家韩国公司,专注于健康和制药领域。该公司在 XKRX 证券交易所上市。